Open Access

Fatty alcohol production in Lipomyces starkeyi and Yarrowia lipolytica

Biotechnology for Biofuels20169:227

Received: 3 March 2016

Accepted: 14 October 2016

Published: 24 October 2016



Current biological pathways to produce biofuel intermediates amenable to separations and catalytic upgrading to hydrocarbon fuels are not cost effective. Previously, oleaginous yeasts have been investigated primarily for lipid production. However, yeasts store neutral lipids intracellularly making recovery difficult and expensive. In addition, once recovered from the cells, lipids are difficult to blend directly with the existing fuels without upgrading. We have, therefore, begun to investigate secreted fatty acid-derived products which can be easily recovered and upgraded to fuels.


In this study, we successfully demonstrate the production of fatty alcohols by the oleaginous yeasts, Yarrowia lipolytica and Lipomyces starkeyi, through expression of the fatty acyl-CoA reductase gene from Marinobactor aquaeolei VT8. This strategy resulted in the production of 167 and 770 mg/L of fatty alcohols in shake flask from Y. lipolytica and L starkeyi, respectively. When using a dodecane overlay during fermentation, 92 and 99% of total fatty alcohols produced by Y. lipolytica and L. starkeyi, respectively, were extracted into the dodecane phase, which compares favorably to the 3 and 50% recovered, respectively, without the dodecane layer. In both oleaginous yeasts, long chain length, saturated fatty alcohols, i.e., hexadecanol (C16:0) and octadecanol (C18:0), were predominant and accounted for more than 85% of the total fatty alcohols produced. To the best of our knowledge, this is the first report of fatty alcohol production in L. starkeyi.


This work demonstrates that the oleaginous yeasts, Y. lipolytica and L. starkeyi, can serve as platform organisms for the production of fatty acid-derived biofuels and bioproducts.


Metabolic engineering Oleaginous yeasts Yarrowia lipolytica Lipomyces starkeyi Fatty alcohols


Oleaginous yeasts have received increasing attention due to their ability to accumulate high intracellular content of neutral lipids, which are considered as alternatives to plant oils for biodiesel production [1]. Among these oleaginous species, Yarrowia lipolytica is a well-studied model organism for genetic and physiological research as well as for industrial applications [25]. The establishment of the genome sequence of Y. lipolytica strain E150 (CLIB99) [6, 7] and the development of critical genetic tools, such as transformation methods [8] and integrative expression cassettes [912], provide a solid platform for metabolic engineering. Compared with Y. lipolytica, L. starkeyi has been less well studied due to the lack of advanced genetic tools and generally insufficient knowledge of its cellular genetics. However, L. starkeyi is otherwise a very attractive host species, due to its high lipid content (~60%) [13] and ability to utilize biomass-derived sugars, including glucose, xylose, mannose, and galactose [14, 15]. These features make L. starkeyi a unique species for developing biofuels. With the very recent development of a transformation protocol [16], genetic engineering now enables L. starkeyi to serve as unique oleaginous yeast for further biofuel research.

Current research on oleaginous yeasts for biofuels applications has mainly focused on lipid production. Increasing lipid content in Y. lipolytica has been widely investigated [12, 1720]. Lipids are stored intracellularly in a neutral form as triacylglycerol (TAG) and can be chemically transesterified to fatty acid methyl and ethyl esters (FAME and FAEE), which serve as biodiesels. Although TAGs are valuable renewable precursors for biodiesel production, they are not directly compatible with existing fuels. In addition, lipid extraction using solvent and upgrading are costly processes. We have, therefore, begun to investigate secreted fatty acid-derived products which can be easily recovered and further upgraded to fuels. Among the fatty acid-derived products in oleaginous yeasts, fatty alcohol is another valuable product having many applications, including detergents and cosmetics. Currently, fatty alcohols are primarily petroleum derived or derived from plants’ oils or animal fats [21, 22] and can be easily upgraded via hydrodeoxigenation processes. Fatty alcohols can also be biologically produced from fatty acyl-CoA by NAD(P)H-dependent fatty acyl-CoA reductase and are generating interest as a renewable biofuel. Microbial production of fatty alcohol was first reported in Escherichia coli and Saccharomyces cerevisiae by introducing a fatty acyl-CoA reductase (far) gene into the host [2327]. In E. coli, fatty acid biosynthesis generates acyl–acyl carrier proteins (acyl-ACP) which is subsequently converted to fatty acid by thioesterase, then to fatty acyl-CoA by acyl-CoA ligase, and finally to fatty alcohols by FAR. Expressing acr1 from Acinetobacter calcoaceticus along with expression of tesA and fadD in E. coli resulted in production of medium chain length fatty alcohols of 60 mg/L [25]. When tesA and fadD were co-expressed with the far gene, Maqu_2220, from Marinobactor aquaeolei VT8, the titer of fatty alcohol reached 422 mg/L in a shake flask and over 1.7 g/L in fed-batch fermenter [23]. Very recently, a novel strategy consisting of enhancing the acyl-CoA pool with expression of an orthogonal type I fatty acid synthase in conjunction with tesA, fadD and the far gene (Maqu_2220 from M. aquaeolei), significantly enhanced the fatty alcohol production in E. coli, achieving a titer of 3.5 g/L [28]. Type I fatty acid synthesis system commonly found in mammals and fungi can be advantageous for fatty alcohol synthesis since it releases fatty acyl-CoA directly which can be used as substrate for FAR. However, despite of this advantage, the fatty alcohol titers in the engineered S. cerevisiae, which co-expressed the far gene, the fatty acid synthesis pathway genes as well as the regulatory genes in lipid metabolism, were relative low, i.e., 93.4 mg/L [24] for the mouse far gene expression, 84 mg/L for the bird far gene expression [29] and 330 mg/L for barn owl far gene expression in shake flasks [30]. In a recent report, expressing barn owl far gene in Y. lipolytica together with dga1 and fao1 knock out led to production of 636.89 mg/L intracellular and 53.32 mg/L extracellular fatty alcohols [31]. In contrast to the low lipid content in Y. lipolytica, some oleaginous yeasts are capable of accumulating up to 60% of lipid intracellularly, which implicates abundant metabolic flux to fatty acyl-CoA. This strong de novo synthesis of the fatty acid pathway can be attractive for fatty alcohol synthesis. Indeed, a very recently report by Fillet et al. showed substantially higher production of fatty alcohol reaching 800 mg/L from glucose in flask and over 8 g/L from sucrose in 7 L bioreactors by the oleaginous yeast Rhodosporidium toruloides expressing the far gene Maqu_2220 [32].

Similarly, as is the case for R. toruloides, L. starkeyi might also be a good source for fatty alcohol production considering its strong de novo synthesis of fatty acids, typically leading to ~60% intracellular neutral lipids. Although L. starkeyi has been genetically intractable due to lack of genetic tools until recently, a workable transformation method was introduced by Calvey et al. [16]. Compared to Y. lipolytica, for which genetic engineering techniques have been well established, engineering L. starkeyi was more challenging. In the present study, we investigated the fatty alcohol production capacity of two oleaginous yeasts, Y. lipolytica and L. starkeyi, following transformation with a heterologous far gene. As shown in Fig. 1 [33], fatty alcohol production is diverted from fatty acyl-CoA instead of going to TAG production . We demonstrated that the far gene, Maqu_2220 from M. aquaeolei VT8, was successfully expressed in both Y. lipolytica and L. starkeyi and enabled the production of fatty alcohols.
Fig. 1

Biosynthetic pathway of fatty alcohol in Yarrowia lipolytica and Lipomyces starkeyi. The yellow-shaded pathway from fatty acyl-CoA to fatty alcohol indicates the engineered steps for the fatty alcohol synthesis described in this work. ACC acetyl-CoA carboxylase; ACL ATP citrate lyase; G3P glyceraldehyde 3-phosphate; DGA diacylglycerolacyltransferase; DHAP dihydroxyacetone phosphate; F-6-P fructose 6-phosphate; FAS fatty acid synthase; G-6-P glucose 6-phosphate; LPA lysophosphatidic acid; MaFAR fatty acid reductase of Marinobactor aquaeolei VT8; OAA oxaloacetate; PD pyruvate dehydrogenase; PL phospholipid; Pyr pyruvate; TAG triacylglycerol. The diagram is based on summary views of lipid biosynthesis in the recent literature described in the text of this paper


Microorganisms and vectors

Yarrowia lipolytica Po1g (MatA, leu2-270, ura3-302:URA3, xpr2-332, and axp-2) and the vector pYLEX1 were purchased from Yeastern Biotech Co. (Taipei, Taiwan). The vector pMT015-YTEFin was constructed by replacing the hp4d promoter of pYLEX1 with the translation elongation factor-1a (TEF) promoter as described in the literature [18]. This promoter was synthesized (Genscript) as a SalI-KpnI fragment and ligated into the appropriately restricted pYLEX1 vector. The gene encoding Maqu_2220, a fatty acyl-CoA reductase (MaFAR) from M. aquaeolei VT8 [21 (Accession: YP_959486), was codon optimized and synthesized (GenScript). The synthesized gene product was ligated with the SnaBI–NsiI double-restricted vector pMT015-YTEFin. This vector also contains a leucine selection marker gene (LEU2) to complement the deletion of the LEU2 gene in the parent strain of Po1g. The resulting plasmid, pYLEX14, was digested with NotI enabling the linearized plasmid to integrate at the PBR docking platform established in the genome of Y. lipolytica Po1g (YLEX expression kit).

Lipomyces starkeyi NRRL Y-11557 used in this study was obtained from National Center for Agricultural Utilization Research, USDA-ARS, Peoria, IL, USA. Genomic DNA was isolated using the Ultraclean Soil DNA Isolation Kit (MoBio Laboratories Inc.). To transform L. starkeyi, a selection plasmid was constructed using the native TDH3 promoter (primers listed in Table 1. EK9, EK10) and PGK1 terminator (EK13, EK14) of L. starkeyi to express the NAT1 gene of Streptomyces noursei encoding resistance to nourseothricin. The promoter and terminator were PCR-amplified from genomic DNA having a 5′ and 3′ regions homologous to a region of pUC19 just upstream of the multicloning site. The SnNAT1 gene (EK11, EK12) was PCR-amplified from pYL16 (Werner Bioagents, Germany) having 5′ and 3′ regions of homologous overlap with the promoter and terminator, respectively, to construct the LsTDH3p-MaFAR-LsPGK1t expression cassette. The plasmid pUC19 (EK15, EK16) was also PCR-amplified with 5′ and 3′ regions of homology to the L. starkeyi promoter and terminators. The PCR products were gel isolated, purified using the Qiaquick Gel Extraction Kit (Qiagen), and assembled as a 4-fragment Gibson assembly reaction (Gibson Assembly Cloning Kit, NEB). This selection vector was designated pEKLs1 and was PCR-amplified (EK23, EK24) for the next construction step. The native PYK1 promoter (EK17, EK21) and GAL1 terminator (EK18, EK22) of L. starkeyi were PCR-amplified from genomic DNA having 5′ and 3′ regions of homology to pEKLs1 upstream of the NAT1 expression cassette The promoter, terminator, and pEKLs1 vector PCR products were gel isolated and used for a three-fragment Gibson assembly. The resulting vector was designated pEKLs2 and allows for the insertion of any gene of interest for overexpression in L. starkeyi by Gibson assembly between the LsPYK1p and LsGAL1t. The gene encoding MaFAR was PCR-amplified from pYLEX14 (described above) having 5′ and 3′ regions of homology to the LsPYK1p and LsGAL1t. The PCR-amplified MaFAR gene and pEKLs2 vector (EK17, EK18) were gel isolated and used for a two-fragment Gibson assembly. Correct insertion of the MaFAR gene was confirmed by DNA sequencing, and the resulting plasmid was named pLS101-4.
Table 1

PCR primers used in this study





































Transformation and selection

Targeted integrative transformation of Y. lipolytica with pYLEX14 was conducted as described by Wei et al. [34] using the YLOS One-step Transformation system included in the YLEX expression kit. For the selection of prototrophic recombinants (Leu+), transformants were grown on solid YNB medium (2% glucose w/v, 0.67% yeast nitrogen base w/o amino acids, 1.5% agar), incubated at 28 °C for 2–4 days.

Random integrative transformation of L. starkeyi was conducted as described by Calvey et al. [16]. A single colony of L. starkeyi was inoculated into YPD medium and incubated at 30 °C and shaken at 225 rpm until OD600 reached 5.2. Cells were harvested by centrifugation at 3000 rpm for 5 min, washed with 25 mL of water and resuspended in 0.5 mL of 0.1 M LiAc. Suspended cells (100 µL) were dispensed into a microcenrifuge tubes and briefly pulsed to collect the cells and remove the LiAc. The collected cells were resuspended in 240 µL of PEG (50% w/v, MW 3650), 30 µL of 1 M LiAc, 3 µL of ssDNA (10 µg/µL), and linearized DNA and water to equal 27 µL (300 µL total volume) and vortexed thoroughly. The mixture was incubated at 30 °C for 3 h without shaking and then treated under a 5-min thermal shock at 40 °C. The cells were pelleted by centrifugation for 15 s, and the supernatant was removed. The cell pellet was resuspended in one mL of YPD medium and incubated at 30 °C and 225 rpm for 3 h. Cells were then centrifuged, resuspended in 0.5 mL of water, and plated on YPD with 30 µg/mL of nourseothricin (ClonNAT). Transformants appeared after 5 days incubation at 30 °C. The successful transformation and integration of the Maqu_2220 gene in both Y. lipolytica and L. starkeyi were verified by PCR amplification (see Table 1 for primer sequences) of a 206 bp fragment internal to the Maqu_2220 gene using extracted genomic DNA as a template.

Culturing of far transformants for fatty alcohol production

Cultures of Y. lipolytica and L. starkeyi far transformants were grown in 250 mL baffled shake flask. For both strains, seed cultures were first prepared in 5 mL of YPD broth in 125 mL flasks. For Y. lipolytica, the seed culture was incubated at 28 °C and 220 rpm. After 24 h, 2.5 mL of seed culture was inoculated into 25 mL of production medium in a 250 mL shake flask and incubated in a shaker at 28 °C and 220 rpm. For L. starkeyi, the seed culture was incubated at 30 °C and 220 rpm. L. starkeyi grew slower compared to Yarrowia, thus we harvested the seed culture of Lipomyces at 36 h instead of 24 h. The production medium inoculated with the seed culture was cultivated at 30 °C and 220 rpm. For the culture with dodecane overlay, 3 mL of dodecane was added to the production medium, 48 h after the cultivation in 250-mL flask was started. For the analysis of fatty alcohol production, cultures were harvested at 5 days unless otherwise stated and centrifuged at 4000 rpm. The cell pellet, supernatant and dodecane phase (if overlaid with dodecane) were separated after centrifugation. Flask experiments were run in triplicates, the data were shown as the average of the triplicates, and error bars represent the standard deviation of the triplicates.

The medium used for fatty alcohol production in this study was mineral medium containing (g/L): (NH4)2SO4, 0.5; KH2PO4, 7.0; Na2HPO4, 2.0; MgSO4·7H2O, 1.5; CaCl2·2H2O, 0.1; FeCl3·6H2O, 0.08; ZnSO4·7H2O, 0.001; CuSO4·5H2O, 0.0001; CoCL2·H2O, 0.0001; MnSO4· 5H2O, 0.0001 and vitamin supplements. The carbon source was glucose (3% w/v). The initial pH value of the medium was pH 6.0. For culturing of the control strain of Y. lipolytica Po1g in mineral medium, leucine was supplemented to the medium at a concentration of 0.1 g/L.

GC–MS analysis for fatty alcohols

Fatty alcohols were extracted from media, cell pellets, and whole culture (media + pellet) using an extraction procedure similar to Steen et al. [25] for analysis (except for the culture with dodecane overlay where samples of dodecane phase were directly used for GC–MS analysis). In brief, 10 μL of a recovery standard consisting of 5 mg/mL tridecanol in ethyl acetate was spiked into 10 mL of sample and vortexed thoroughly. Spiked samples were extracted with 40% (v/v) ethyl acetate. To facilitate extraction, samples were hand shaken for 2 min before centrifugation at 4 °C for 10 min at 3000 rpm. A blank sample consisting of 10 mL of water spiked with recovery standard was also run with each extraction set. If the two phases formed an emulsion, samples were placed in a freezer (0 °C) overnight before continuing. The ethyl acetate phase was recovered and dried down under a steady stream of N2 to a little less than 1 mL before being quantitatively transferred to a glass GC vial, and finally brought to a 1 mL total volume.

Analysis for fatty alcohols was performed on a 7890N Agilent GC system with an Agilent DB-Wax column, 30 m × 0.25 mm × 0.25 μm. The GC parameters used were as follows: 1 μL injection, split ratio 10:1, injector temp 250 °C, constant flow 1 mL/min He; oven ramp 100 °C for 1 min, 25 °C/min to 200 °C and hold for 1 min, 5 °C/min to 250 °C and hold for 7 min; FID detector at 280 °C, 40 mL/min H2, 450 mL/min zero air, 30 mL/min makeup He, collection at 5 Hz. Saturated and unsaturated fatty alcohols were quantified using two fatty alcohol standards (NuChek GLC 32C and 34C). A similar program was run on the GC–MS to verify peak identities.

Where applicable, samples were overlain with 10% (v/v) dodecane during growth. The dodecane layer was recovered and diluted as necessary before being run on the GC-FID as described above. All the samples were analyzed in triplicates, and the standard deviations were <0.35%.

Lipid determination

The cell biomass was harvested by centrifugation and freeze dried for lipid determination. 0.2 mL chloroform–methanol (2:1 v/v) was added to 7–11 mg of lyophilized biomass to solubilize the lipids and simultaneously transesterify the lipids in situ with 0.3 mL HCl–methanol (95% v/v) for 1 h at 85 °C. The resulting FAMEs were extracted with 1 mL hexane at room temperature for 1 h and analyzed by gas chromatography GC-FID (Agilent 6890N) using DB5-MS column (Agilent, USA). Quantification of the FAMEs was based on integration of individual fatty acid peaks in the chromatograms and quantified using a 5-point calibration curve of a mixed, even carbon chain FAME standard of 14 individual fatty acids (C8–C24, SIGMA cat# 18918). The total lipid content was calculated as the sum of the even numbered FAMEs contributions. All the samples were analyzed in triplicates, and the standard deviations were <0.35%.

Results and discussion

Production of fatty alcohols in far-expressing Y. lipolytica Yl[FAR]

A well-known and commercially available YLEX expression kit was used for Y. lipolytica transformation. The successful transformation and integration of the Maqu_2220 gene in Y. lipolytica was verified by PCR amplification as described in ''Methods'' section. Due to the targeted integration at a specific docking site in Y. lipolytica, effects on expression due to random integration localization are not expected. Three far transformants were cultured and characterized in terms of cell growth and fatty alcohol production, and they turned to show very similar growth and fatty alcohol production profile. Thus only one transformant was chosen for further study. Expression of the far gene in Y. lipolytica did not impact cell growth (Fig. 2a) and resulted in the production of up to 167 mg/L of fatty alcohols in mineral medium while the control Y. lipolytica Po1g did not produce any fatty alcohols. This titer was approximately three times higher than that observed with the single mouse mfar1 gene expression in S. cerevisiae (56.5 mg/L) [24] and six times higher than the bird far gene expression in S. cerevisiae (26 mg/L) [29]. Analyzing the cell pellets and supernatant separately showed that 97% of the produced fatty alcohol was associated with or trapped in the cells while only 3% was secreted (Table 2). This result is consistent with the recent research about Y. lipolytica that most of the fatty alcohols were retained intracellularly when TaFAR1 gene was expressed in Y. lipolytica [31]. Using a 10% (v/v) dodecane overlay during growth, 92.5% of the produced fatty alcohols were extracted into the dodecane phase, while only 5% remained associated with cells (Table 2). This high extraction efficiency by dodecane would undoubtedly benefit downstream separation processes.
Fig. 2

Cell growth (a) and fatty alcohols production (b) by far-expressing Y. lipolytica growing on mineral medium. The control represents empty vector control

Table 2

Fatty alcohols distribution in Y. lipolytica fermentation broth samples with and without dodecane overlay


Sample volume (ml)

Fatty alcohols in dodecane (mg)

Fatty alcohols in supernatant (mg)

Fatty alcohols in pellet (mg)

Total fatty alcohols (mg)

Without dodecane



0.24 ± 0.04

7.78 ± 0.10

8.02 ± 0.10

With dodecane


8.52 ± 0.02

0.23 ± 0.02

0.46 ± 0.02

9.21 ± 0.05

In this study, we also compared fatty alcohols production titers with and without dodecane overlays during the incubation. Our characterizations show that 14% more fatty alcohols were detected in dodecane-overlaid cultures than without dodecane overlays (Fig. 2b). This may be due to the inhibition or toxicity of fatty alcohols to the cells in non dodecane-overlaid cultures. We also found differences in the concentrations of fatty alcohols between the whole culture analysis and the pellet plus supernatant determined separately. For example, for the same culture, we found 21% less fatty alcohols from the whole culture analysis compared to the separate analysis of cells and supernatant (Table 3). This lower value in the measured fatty alcohol titer by the whole culture analysis method could be due to a lower extraction efficiency when cells and medium were mixed together. Overlaying dodecane appears to be the most efficient method to recover the produced fatty alcohols, thus in the following experiments, we overlaid dodecane on all the culture broths, and fatty alcohols in dodecane phase were measured.
Table 3

Fatty alcohols in L. starkeyi fractions: analyzing whole culture or analyzing cells and supernatant separately


Fatty alcohols in pellets (mg/L)

Fatty alcohols in supernatant (mg/L)

Total fatty alcohols (mg/L)

Separate fractions

140.8 ± 2.5

4.2 ± 0.2

145.0 ± 2.2

Whole culture



115.0 ± 5.0

Lipid accumulation and fatty alcohol composition in Yl[FAR]

Overexpressing the far gene in Y. lipolytica led to 15% decrease in lipid content (7.9 ± 0.1% compared to the parent strain 9.3 ± 0.3%), indicating that the carbon flux originally going to TAG synthesis might partially be redirected toward fatty alcohol production. Note that the lipid composition profile in the far transformant was identical to that of the parent strain Y. lipolytica Po1g, and the lipid profile of the parent strain is consistent with the previous studies [18], i.e., C16:0 and C18:1 are two major fatty acids species (see Fig. 3a).
Fig. 3

Lipid and fatty alcohol compositions in Yl[FAR] growing on mineral medium at 5 days. Fermentation medium was overlaid with dodecane. a Lipid composition. b Fatty alcohol composition. The control represents empty vector control

The composition of the fatty alcohols produced in Yl[FAR] is shown in Fig. 3b. The fatty alcohols with a long chain length, i.e., hexadecanol (C16:0), octadecanols (C18:0), and (C18:1) accounted for 53.1, 36.3, and 10.4%, respectively, of the total alcohols. It is noteworthy that saturated fatty alcohols were predominant in all the produced fatty alcohols, which could be beneficial for downstream upgrading to hydrocarbons as less hydrogen is needed in the hydrotreating process. The fatty alcohol composition profile of MaFAR transformant in this study is very similar to the recently published research on fatty alcohol production in Y. lipolytica, although a different source of far gene was expressed. Does this indicate that fatty alcohol composition is species specific? More cases of studies on different far gene expressions in Y. lipolytica will help to answer this question.

Production of fatty alcohols in far-expressing L. starkeyi Ls[FAR]

Oleaginous yeasts require fatty acyl-CoA for de novo biosynthesis of TAG. Fatty acyl-CoA is a central intermediate in fatty acid synthesis which can be converted to various fatty acid-derived products including TAG and fatty alcohols via different enzymes. Overexpressing the far gene in oleaginous yeast is a straight forward strategy to bypass the TAG synthesis pathway by pulling fatty acids (in fatty acyl-CoA form) toward fatty alcohols production. The lipid content in the parent strain Y. lipolytica Po1g, used in this study, was less than 15% percent, whereas lipid content in L. starkeyi was greater than 50%. As L. starkeyi accumulates higher levels of TAG, we assume higher levels of fatty acyl-CoA are produced as an intermediate in L. starkeyi than in Y. lipolytica. Therefore, more fatty acyl-CoA should be available for conversion to fatty alcohols when overexpressing the far gene. To this end, the same MaFAR gene was also expressed in L. starkeyi NRRL Y-11557.

The successful transformation and integration of the Maqu_2220 gene in L. starkeyi was verified by PCR amplification as described in ''Methods'' section. Due to the nature of random integration and the possibility of effects on gene expression due to integration localization, 20 transformants with random insertions of the far gene were chosen for characterization. All the transformants were confirmed to produce fatty alcohols, albeit at varied titers (Fig. 4). Considering the random insertion of far gene, this variation in fatty alcohols production among the transformants is not unexpected and could be due to different copy numbers or locations of the inserted far gene in the genome. Further work will be done to understand the mechanism involved. Among the 20 transformants found, transformants 6 and 10 produced more fatty alcohols than the others in mineral medium, 720 and 770 mg/L after 5 days, respectively. This production titer is comparable to the same far gene expression in R. toruloides grown on glucose medium. The higher level of fatty alcohol production may be related to the robust fatty acid synthesis in L. starkeyi as indicated by high lipid content in wild type cells. Moreover, the level of the fatty alcohols produced in L. starkeyi from mineral medium containing 3% glucose is very comparable to the fatty alcohol production by another high lipid-accumulating oleaginous yeast R. toruloides, 0.8 g/L fatty alcohols produced from YP medium containing 4% glucose [32].
Fig. 4

Fatty alcohol production by far-expressing L. starkeyi transformants on mineral medium at 5 days. Fermentation medium was overlaid with dodecane. C represents empty vector control

Lipid accumulation and fatty alcohol composition in far-expressing Lipomyces Ls[FAR]

The FAME composition data of the wild type L. starkeyi in our study were consistent with the previous studies on this strain, i.e., C16:0 and C18:1 fatty acids were predominant [13]. Similar to Y. lipolytica, expression of the far gene in L. starkeyi also led to a decrease in lipid content while lipid composition profiles remained the same as the parental control (Fig. 5). Considering transformant 10, for example, FAME content was found to decrease to 40.6% at 5 days, compared to 56.9% in the control.
Fig. 5

Lipid compositions in Ls[FAR] transformant 10 growing on mineral medium at 5 days. The standard deviation of triplicates was <0.35%. The control represents empty vector control

Although fatty alcohols were produced by expressing the far gene in L. starkeyi, we found that there remained a large amount of lipid accumulation in the cells, even though we tried to bypass the TAG synthesis pathway by redirecting carbon flux to fatty alcohols production. A much stronger “pull” enhancing MaFAR expression is needed. In addition to the “pull” strategy, blocking TAG synthesis, i.e., disruption of the dga gene which encodes for diacylglycerol acyltransferase, the final enzyme for TAG synthesis, is another strategy for further enhancing fatty alcohol production. Also, as demonstrated in recent research [31], eliminating fatty alcohol degradation pathway, might be another strategy deserving a try. However, considering the complex nature of this species and for other unknown genetic reasons, the subsequent knocking out genes is very challenging. To this end, a more efficient transformation system able to achieve targeted gene knock-out must be developed.

The patterns of fatty alcohols composition in L. starkeyi far transformants were similar to that of Y. lipolytica. In all the far transformants, long chain fatty alcohols i.e., saturated hexadecanol (C16:0) and octadecanol (C18:0) accounted for 85–88% of the total fatty alcohols, whereas unsaturated octadecanol (C18:1) accounted for 12–15%. This result is in contrast to the fatty alcohols composition in R. toruloides, which showed a very high content of unsaturated oleyl alcohol (C18:1, 69%) and low contents of saturated hexadecanol (C16:0) and octadecanol (C18:0) (12% and 19%, respectively) [32]. In transformants 6 and 10, the two far transformants with the highest fatty alcohols titers, a small fraction (about 2.5%) of long chain fatty alcohol (C20:0) was also observed (Fig. 6).
Fig. 6

Fatty alcohol compositions in Ls[FAR] transformants 6 and 10 growing on mineral medium at 5 days

The fatty alcohols profiles in Y. lipolytica and L. starkeyi are pretty similar showing that saturated C16:0 and C18:0 fatty alcohols predominate, accounting for 85–90% of total fatty alcohols. It is noteworthy that this is different from the composition profiles of R. toruloides and E. coli ever reported, although the same MaFAR was expressed [23, 32]. In R. toruloides, unsaturated oleyl alcohol (C18:1) was predominant, accounting for 57% of the total fatty alcohols [32]. In E. coli, C16:0 and C18:1 were major components, but about 15% of shorter chain length C12:0 and C14:0 fatty alcohols also existed [23]. This indicates that the far gene Maqu_2220 has broad substrate specificity. The difference in composition profile for the same far gene in different strains might be related to different growth medium and culturing conditions. Carbon chain lengths and degrees of saturation affect the physiochemical properties of fatty alcohols enabling different applications. By expressing different far genes and optimizing medium and fermentation conditions (e.g., different carbon sources), the carbon chain length of fatty alcohols may be tailored according to different substrate specificities of various far genes, and this could be explored in future work.

Fatty alcohol production with glucose and xylose as substrate

An important characteristic of L. starkeyi is that it can utilize both glucose and xylose. The profile of fatty alcohol production by transformant 10 with glucose as substrate is depicted in Fig. 7a. Cell growth reached the stationary phase around 72 h even though the sugars were not completely consumed. The limited nitrogen content (0.5 g/L) for these cultures likely lead to a cessation of cell growth while still allowing fatty alcohol production. Lipid accumulation reached 40% within 72 h and slowly decreased thereafter, although glucose was still being consumed by the strain. It is noteworthy that fatty alcohols production increased as cultivation continued, reaching 735 mg/L at 144 h. At an extended fermentation, the fatty alcohols titer could reach up to about 800 mg/L at 192 h. After 72 h, it appears that the glucose consumption did not further contribute to cell growth or lipid synthesis, but fatty alcohols production continued at the same rate. Interestingly, once the glucose were exhausted at 120 h, the production of fatty alcohols continued but at a slower rate. This could be due to continued metabolic activity (e.g., de novo fatty alcohol production) or continued secretion of fatty alcohols that had built up inside of the cell previously. Clearly further experiments are warranted to understand the timing and rates of intracellular fatty alcohol production. Also of interest is the rapid use of xylose by L. starkeyi. Typically glucose is the preferred carbon source of any given organism, however L. starkeyi can utilize xylose as well as glucose.
Fig. 7

Cell growth, fatty alcohols, and lipid production by Ls[FAR] transformant 10 on mineral medium. a Glucose as substrate. b Xylose as substrate

The profile of fatty alcohol production by transformant 10 with xylose as substrate is similar to that using glucose as substrate, except that cell mass and the fatty alcohol titer were slightly lower on xylose than that on glucose (Fig. 7b). It was found that 587 mg/L fatty alcohols were produced at 144 h. With an extended incubation, the fatty alcohols titer could reach up to 710 mg/L at 192 h. We noted that the rate of xylose utilization is as fast as that of glucose, which is advantageous for utilizing biomass-derived sugars as feedstocks. The ability of L. starkeyi capable of producing high level of fatty alcohols from xylose makes it very attractive to use lignocellulosic biomass feedstocks. Although R. toruloides was shown to produce fatty alcohol from mixture of glucose and xylose, the levels are very low (220 mg/L); However, the rate of the fatty alcohol production in L. starkeyi is rather slow as compared to R. toruloides. [32].

The yields of fatty alcohols growing on glucose or xylose are summarized in Table 4. From these data, we note that the yields were low, which indicates that other steps in fatty alcohol synthesis pathway might be rate-limiting. Engineering other genes in fatty acid synthesis pathway, i.e., knocking out genes leading to TAG synthesis or overexpressing genes leading to more accumulation of fatty acyl-CoA might help to achieve high fatty alcohol titers.
Table 4

Yields of fatty alcohols on glucose or xylose as substrate (g/g glucose or xylose)


Time (h)









Yield on glucose (g/g)









Yield on xylose (g/g)









During fermentations on glucose and xylose, the patterns of fatty alcohol composition changing with time were similar (Fig. 8). At early stage, i.e., 24 h, C18:0 fatty alcohol was preferentially produced. After 72 h, the percentage of C16:0 fatty alcohol increased, while C18:0 fatty alcohols dropped. In contrast, the percentage of C18:1 fatty alcohol remained nearly constant throughout the fermentation. It is noteworthy that, regardless of the change in the ratios of C16:0 and C18:0 fatty alcohols, the amounts of C16 and C18 fatty alcohols together accounted for about 85–90% of total fatty alcohols throughout the cultivation process.
Fig. 8

Pattern of fatty alcohol composition during fatty alcohol production process. a Glucose as substrate. b Xylose as substrate

Distribution of fatty alcohols produced by far-expressing L. starkeyi

The distributions of the fatty alcohols produced by far-expressing Y. lipolytica and L. starkeyi were quite different. In Y. lipolytica, only 3% of the total was secreted, while in L. starkeyi, more fatty alcohols, at least 50% of the total was secreted from the cells into the medium. The partition of fatty alcohols in L. starkeyi is similar to that in far-expressing R. toruloides where 80% of fatty alcohols were secreted into culturing broth [32]. In the beginning, this striking difference in secretion led us think that there might be a threshold for fatty alcohols to secrete out instead of retaining intracellularly because the fatty alcohol titers in L. starkeyi and R. toruloides were much higher compared to that in Y. lipolytica. However, we got the same partition profile in low fatty alcohol producing L. starkeyi transformants (~200 mg/L fatty alcohols), i.e., more than half of the total fatty alcohols were secreted into the broth. This difference in fatty alcohol secretion titers for these strains could be related to the different permeabilities of cell membranes. Therefore, a structural and compositional analysis of the cell membranes might help elucidate the mechanism underlying the partition phenomena. Undoubtedly, the secretion of fatty alcohols could be beneficial for downstream product processing (e.g., separations), as well as for cell viability, considering the potential for fatty alcohols to be toxic.


In summary, this study demonstrates fatty alcohol production by the oleaginous yeast, Y. lipolytica and L. starkeyi. By expressing the far gene from M. aquaeolei VT8 in both strains, 167 and 770 mg/L fatty alcohols were generated by Y. lipolytica and L. starkeyi growing on glucose, respectively. Furthermore, Y. lipolytica has been considered a model strain for the study of fatty acid synthesis in recent years. Our work demonstrates that, in addition to Y. lipolytica, L. starkeyi can also serve as a platform organism for production of fatty acid-derived biofuels and bioproducts via metabolic engineering. Our results show that L. starkeyi far gene transformant was able to produce fatty alcohols from both glucose and xylose, providing a basis for further engineering aimed at increasing fatty alcohol titer on cellulosic biomass feedstocks. To this end, more strategies are needed to enhance the fatty alcohol production, e.g., increase the copy number of the far gene. We believe that strain and process development can be combined to significantly contribute to the goal of producing scalable and cost-effective fatty alcohols from renewable biomass.



fatty acyl-CoA reductase




fatty acid methyl esters


diacylglycerol acyltransferase


Authors’ contributions

WW, HW, MZ, and MEH conceived and designed the experiments. WW, HW, EK, and QX designed the constructs, and conducted genetic transformation and transformants characterization. SVW conducted FAME and fatty alcohol analysis. WW drafted the manuscript. HW, EK, and MZ contributed to the manuscript preparation. MEH revised the manuscript. All the authors read and approved the final manuscript.


The authors would like to thank Dr. David K. Johnson for his keen edits on this manuscript.

Competing interests

The authors declare that they have no competing interests.

Availability of supporting data

All data were included in the manuscript, and further information is provided upon request.

Consent for publication

All the authors agree to the publication of this manuscript.


This work was funded by the U.S. Department of Energy’s Bioenergy Technology Office (DOE-BETO) under Contract No. DE-AC36-08-GO28308 with NREL.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Biosciences Center, National Renewable Energy Laboratory
National Bioenergy Center, National Renewable Energy Laboratory


  1. Ratledge C, Wynn JP. The biochemistry and molecular biology of lipid accumulation in oleaginous microorganisms. Adv Appl Microbiol. 2002;51:1–51.View ArticleGoogle Scholar
  2. Barth G, Gaillardin C. Physiology and genetics of the dimorphic fungus Yarrowia lipolytica. FEMS Microbiol Rev. 1997;19(4):219–37.View ArticleGoogle Scholar
  3. Wolf DA. Nonconventional yeasts in biotechnology, a handbook. Recherche. 1996;67:02.Google Scholar
  4. Madzak C. Yarrowia lipolytica: recent achievements in heterologous protein expression and pathway engineering. Appl Microbiol Biotechnol. 2015;99(11):4559–77.View ArticleGoogle Scholar
  5. Zhu Q, Jackson EN. Metabolic engineering of Yarrowia lipolytica for industrial applications. Curr Opin Biotechnol. 2015;36:65–72.View ArticleGoogle Scholar
  6. Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S, Lafontaine I, De Montigny J, Marck C, Neuvéglise C, Talla E. Genome evolution in yeasts. Nature. 2004;430(6995):35–44.View ArticleGoogle Scholar
  7. Sherman D, Durrens P, Iragne F, Beyne E, Nikolski M, Souciet JL. Genolevures complete genomes provide data and tools for comparative genomics of hemiascomycetous yeasts. Nucleic Acids Res. 2006;34(suppl 1):D432–5.View ArticleGoogle Scholar
  8. Chen DC, Yang BC, Kuo TT. One-step transformation of yeast in stationary phase. Curr Genet. 1992;21(1):83–4.View ArticleGoogle Scholar
  9. Davidow LS, Apostolakos D, O’Donnell MM, Proctor AR, Ogrydziak DM, Wing RA, Stasko I, DeZeeuw JR. Integrative transformation of the yeast Yarrowia lipolytica. Curr Genet. 1985;10(1):39–48.View ArticleGoogle Scholar
  10. Juretzek T, Le Dall MT, Mauersberger S, Gaillardin C, Barth G, Nicaud JM. Vectors for gene expression and amplification in the yeast Yarrowia lipolytica. Yeast. 2000;18(2):97–113.View ArticleGoogle Scholar
  11. Dall MT, Nicaud JM, Gaillardin C. Multiple-copy integration in the yeast Yarrowia lipolytica. Curr Genet. 1994;26(1):38–44.View ArticleGoogle Scholar
  12. Blazeck J, Hill A, Liu L, Knight R, Miller J, Pan A, Otoupal P, Alper HS. Harnessing Yarrowia lipolytica lipogenesis to create a platform for lipid and biofuel production. Nat Commun. 2014;5:3131.View ArticleGoogle Scholar
  13. Lin J, Shen H, Tan H, Zhao X, Wu S, Hu C, Zhao ZK. Lipid production by Lipomyces starkeyi cells in glucose solution without auxiliary nutrients. J Biotechnol. 2011;152(4):184–8.View ArticleGoogle Scholar
  14. Sitepu IR, Garay LA, Sestric R, Levin D, Block DE, German JB, Boundy-Mills KL. Oleaginous yeasts for biodiesel: current and future trends in biology and production. Biotechnol Adv. 2014;32(7):1336–60.View ArticleGoogle Scholar
  15. Zhao X, Kong X, Hua Y, Feng B, Zhao ZK. Medium optimization for lipid production through co-fermentation of glucose and xylose by the oleaginous yeast Lipomyces starkeyi. Eur J Lipid Sci Technol. 2008;110(5):405–12.View ArticleGoogle Scholar
  16. Calvey CH, Willis LB, Jeffries TW. An optimized transformation protocol for Lipomyces starkeyi. Curr Genet. 2014;60(3):223–30.View ArticleGoogle Scholar
  17. Beopoulos A, Mrozova Z, Thevenieau F, Le Dall M-T, Hapala I, Papanikolaou S, Chardot T, Nicaud J-M. Control of lipid accumulation in the yeast Yarrowia lipolytica. Appl Environ Microbiol. 2008;74(24):7779–89.View ArticleGoogle Scholar
  18. Tai M, Stephanopoulos G. Engineering the push and pull of lipid biosynthesis in oleaginous yeast Yarrowia lipolytica for biofuel production. Metab Eng. 2013;15:1–9.View ArticleGoogle Scholar
  19. Morin N, Cescut J, Beopoulos A, Lelandais G, Le Berre V, Uribelarrea J-L, Molina-Jouve C, Nicaud J-M. Transcriptomic analyses during the transition from biomass production to lipid accumulation in the oleaginous yeast Yarrowia lipolytica. Plos ONE. 2011;6(11):e27966.View ArticleGoogle Scholar
  20. Dulermo T, Nicaud J-M. Involvement of the G3P shuttle and β-oxidation pathway in the control of TAG synthesis and lipid accumulation in Yarrowia lipolytica. Metab Eng. 2011;13(5):482–91.View ArticleGoogle Scholar
  21. Keim W. Oligomerization of ethylene to α-olefins: discovery and development of the shell higher olefin process (SHOP). Angew Chem Int Ed. 2013;52(48):12492–6.View ArticleGoogle Scholar
  22. Noweck K, Grafahrend W. Fatty alcohols. In: Elvers B, editor. Ullmann’s encyclopedia of industrial chemistry. Weinheim: Wiley; 2006.Google Scholar
  23. Liu A, Tan X, Yao L, Lu X. Fatty alcohol production in engineered E. coli expressing Marinobacter fatty acyl-CoA reductases. Appl Microbiol Biotechnol. 2013;97(15):7061–71.View ArticleGoogle Scholar
  24. Runguphan W, Keasling JD. Metabolic engineering of Saccharomyces cerevisiae for production of fatty acid-derived biofuels and chemicals. Metab Eng. 2014;21:103–13.View ArticleGoogle Scholar
  25. Steen EJ, Kang Y, Bokinsky G, Hu Z, Schirmer A, McClure A, Del Cardayre SB, Keasling JD. Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature. 2010;463(7280):559–62.View ArticleGoogle Scholar
  26. Youngquist JT, Schumacher MH, Rose JP, Raines TC, Politz MC, Copeland MF, Pfleger BF. Production of medium chain length fatty alcohols from glucose in Escherichia coli. Metab Eng. 2013;20:177–86.View ArticleGoogle Scholar
  27. Zheng Y-N, Li L-L, Liu Q, Yang J-M, Wang X-W, Liu W, Xu X, Liu H, Zhao G, Xian M. Optimization of fatty alcohol biosynthesis pathway for selectively enhanced production of C12/14 and C16/18 fatty alcohols in engineered Escherichia coli. Microb Cell Fact. 2012;11(1):1.View ArticleGoogle Scholar
  28. Haushalter RW, Groff D, Deutsch S, The L, Chavkin TA, Brunner SF, Katz L, Keasling JD. Development of an orthogonal fatty acid biosynthesis system in E. coli for oleochemical production. Metab Eng. 2015;30:1–6.View ArticleGoogle Scholar
  29. Tang X, Chen WN. Enhanced production of fatty alcohols by engineering the TAGs synthesis pathway in Saccharomyces cerevisiae. Biotechnol Bioeng. 2015;112(2):386–92.View ArticleGoogle Scholar
  30. Feng X, Lian J, Zhao H. Metabolic engineering of Saccharomyces cerevisiae to improve 1-hexadecanol production. Metab Eng. 2015;27:10–9.View ArticleGoogle Scholar
  31. Wang G, Xiong X, Ghogare R, Wang P, Meng Y, Chen S. Exploring fatty alcohol-producing capability of Yarrowia lipolytica. Biotechnol Biofuels. 2016;9(1):1.View ArticleGoogle Scholar
  32. Fillet S, Gibert J, Suárez B, Lara A, Ronchel C, Adrio JL. Fatty alcohols production by oleaginous yeast. J Ind Microbiol Biotechnol. 2015;42(11):1463–72.View ArticleGoogle Scholar
  33. Dulermo R, Gamboa-Meléndez H, Ledesma-Amaro R, Thévenieau F, Nicaud J-M. Unraveling fatty acid transport and activation mechanisms in Yarrowia lipolytica. Biochim Biophys Acta. 2015;1851(9):1202–17.View ArticleGoogle Scholar
  34. Wang W, Wei H, Alahuhta M, Chen X, Hyman D, Johnson DK, Zhang M, Himmel ME. Heterologous expression of xylanase enzymes in lipogenic yeast Yarrowia lipolytica. PLoS ONE. 2014;9(12):e111443.View ArticleGoogle Scholar


© The Author(s) 2016